Patent Assignment
Reel/Frame 061297/0990
Change of Address
Recorded: 2022-08-22
Pages: 6
Assignor
INTERCEPT PHARMACEUTICALS, INC.
Executed: 2022-08-18
Assignee
INTERCEPT PHARMACEUTICALS, INC.
305 MADISON AVENUE, MORRISTOWN, NEW JERSEY, 07960
Covered Properties
(48)
Farnesoid X receptor modulators
Farnesoid X Receptor Modulators
Treatment of Fibrosis Using Fxr Ligands
Methods of Treating Cancer
Pharmaceutical Compositions for Combination Therapy
Fxr Agonist Compositions for Combination Therapy
Steroids as Agonists for Fxr
Treatment of Pulmonary Disease
Application:
15/652,777 →
Publication:
US 2018/0064729
Methods of Treating Cancer
Application:
15/711,205 →
Publication:
US 2018/0256600
TGR5 Modulators and Methods of Use Thereof
Methods for Preparation of Bile Acids and Derivatives Thereof
Methods and Intermediates for the Preparation Bile Acid Derivatives
Methods for the Preparation of Obeticholic Acid and Derivatives Thereof
Methods and Intermediates for the Preparation of Bile Acid Derivatives
Compositions of Obeticholic Acid and Methods of Use
Medicine Obtained by Combining FXR Agonist and ARB
Oral Preparation of Obeticholic Acid
Film-Coated Tablet Having High Chemical Stability of Active Ingredient
Methods for the Preparation of Obeticholic Acid and Derivatives Thereof
Farnesoid X Receptor Modulators
Preparation and Uses of Obeticholic Acid
Application:
16/189,559 →
Publication:
US 2019/0153020
Treatment of Fibrosis Using Fxr Ligands
Crystalline Forms of a Bile Acid Derivative
Application:
16/337,982 →
Publication:
US 2020/0024299
Pharmaceutical Compositions of a Bile Acid Derivative and Microbiome and Uses Thereof
Application:
16/486,873 →
Publication:
US 2020/0164005
Compositions of Obeticholic Acid and Methods of Use
Application:
16/596,216 →
Publication:
US 2020/0046735
Compositions of Obeticholic Acid and Methods of Use
Application:
16/596,741 →
Publication:
US 2020/0046736
Compositions of Obeticholic Acid and Methods of Use
Application:
16/597,412 →
Publication:
US 2020/0054650
Isotopically Labeled Bile Acid Derivatives
Farnesoid X Receptor Modulators
TGR5 Modulators and Methods of Use Thereof
Preparation and Uses of Obeticholic Acid
Application:
17/142,870 →
Publication:
US 2021/0395293
Treatment of Fibrosis Using Fxr Ligands
Application:
17/211,033 →
Publication:
US 2021/0346400
Farnesoid X Receptor Modulators
Application:
17/228,819 →
Publication:
US 2021/0228599
Farnesoid X Receptor Modulators
Treatment and Prevention of Intestinal Inflammatory Diseases with a Bile Acid Derivative
Application:
17/428,029 →
Publication:
US 2022/0096495
Pharmaceutical Compositions Comprising a Fxr Agonist and a Fibrate for Use in the Treatment of Cholestatic Liver Disease
Application:
17/615,186 →
Publication:
US 2022/0226350
Methods and Intermediates for the Preparation Bile Acid Derivatives
Application:
62/222,943 →
Methods of Treating Cancer
Application:
62/321,816 →
Methods for the Preparation of Obeticholic Acid and Derivatives Thereof
Application:
62/324,405 →
Crystalline Forms of a Bile Acid Derivative
Application:
62/402,813 →
Pharmaceutical Compositions of a Bile Acid Derivative and Microbiome and Uses Thereof
Application:
62/462,658 →
Methods of Treating Cancer
Application:
62/468,259 →
Methods and Intermediates for the Preparation of Bile Acid Derivatives
Application:
62/523,937 →
Isotopically Labeled Bile Acid Derivatives
Application:
62/536,326 →
Treatment and Prevention of Intestinal Inflammatory Diseases with a Bile Acid Derivative
Application:
62/801,066 →
Pharmaceutical Compositions for Combination Therapy
Application:
62/854,859 →
Methods of Treating Coronaviral Infection with Obeticholic Acid
Application:
63/088,571 →
Methods and Intermediates for the Preparation of Bile Acid Derivatives
Application:
63/222,706 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 20, 2015
From: PELLICCIARI, ROBERTO
To: TES PHARMA S.R.L.
Reel/Frame 034756/0671 →
Assignment of Assignor's Interest
Jun 26, 2015
From: TES PHARMA S.R.L.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 035916/0234 →
Assignment of Assignor's Interest
Mar 23, 2018
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 045328/0873 →
Assignment of Assignor's Interest
Oct 5, 2018
From: WHITLEY, PAUL E; LOPEZ, FLAVIO CHAVEZ; IORGA, KAYLA R.
To: PATHEON API SERVICES, INC.
Reel/Frame 047078/0970 →
Assignment of Assignor's Interest
Dec 21, 2018
From: FIORUCCI, STEFANO; PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 047839/0229 →
Assignment of Assignor's Interest
Jan 11, 2019
From: SCHAAB, KEVIN
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 047963/0480 →
Assignment of Assignor's Interest
Jan 28, 2019
From: BANALES ASURMENDI, JESUS MARIA; FERNANDEZ DE PIEROLA, LUIS BUJANDA; PERUGORRIA MONTIEL, MARIA JESUS; AZPARREN, OIHANE ERICE
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 048153/0597 →
Assignment of Assignor's Interest
Mar 18, 2019
From: MOSCHETTA, ANTONIO
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 048619/0957 →
Assignment of Assignor's Interest
Aug 14, 2019
From: PELLICCIARI, ROBERTO; GIOIELLO, ANTIMO
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 050047/0555 →
Assignment of Assignor's Interest
Aug 23, 2019
From: PRUZANSKI, MARK; ADORINI, LUCIANO
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 050151/0627 →
Assignment of Assignor's Interest
Oct 3, 2019
From: NAMISAKI, TADASHI; YOSHIJI, HITOSHI
To: NARA MEDICAL UNIVERSITY
Reel/Frame 050615/0642 →
Assignment of Assignor's Interest
Dec 4, 2019
From: KIM, MYOUNG GOO; LEWIS II, RONALD D; YANIK, MATHEW; GALVIN, GABRIEL
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 051176/0647 →
Assignment of Assignor's Interest
Dec 4, 2019
From: LEUSINK, FREDERIK RONALD; KONING, BARTJAN; HENSEL, THOMAS
To: SYNCOM, B.V.
Reel/Frame 051176/0499 →
Assignment of Assignor's Interest
Dec 11, 2019
From: LANCASTER, RICHARD GAIL; OLMSTEAD, KAY K
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 051242/0845 →
Assignment of Assignor's Interest
Dec 11, 2019
From: KAGIHIRO, MASASHI; TAOKA, IKUKO; MATONO, MITSUHIRO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 051242/0525 →
Assignment of Assignor's Interest
Dec 11, 2019
From: LANCASTER, RICHARD GAIL; OLMSTEAD, KAY K; PRUZANSKI, MARK; SHAPIRO, DAVID
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 051251/0340 →
Assignment of Assignor's Interest
Dec 11, 2019
From: KAGIHIRO, MASASHI; TAOKA, IKUKO; MATONO, MITSUHIRO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 051242/0031 →
Assignment of Assignor's Interest
Jan 22, 2020
From: PELLICCIARI, ROBERTO; GIOIELLO, ANTIMO; KIM, MYOUNG GOO; LEWIS II, RONALD D
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 051584/0177 →
Assignment of Assignor's Interest
Jan 22, 2020
From: SYNCOM, B.V.
To: INTERCEPT PHARMACEUTICALS, INC
Reel/Frame 051584/0307 →
Assignment of Assignor's Interest
Jul 8, 2020
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 053145/0719 →
Assignment of Assignor's Interest
Aug 25, 2020
From: PERRON-SIERRA, FRANCOISE; SEEDORF, KLAUS
To: LES LABORATOIRES SERVIER
Reel/Frame 053599/0563 →
Assignment of Assignor's Interest
Aug 25, 2020
From: PELLICCIARI, ROBERT; GIOIELLO, ANTIMO; MACCHIARULO, ANTONIO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 053599/0534 →
Assignment of Assignor's Interest
Oct 7, 2020
From: PRUZANSKI, MARK; ADORINI, LUCIANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 053995/0807 →
Assignment of Assignor's Interest
Oct 22, 2020
From: PATHEON API SERVICES INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 054138/0284 →
Assignment of Assignor's Interest
Oct 22, 2020
From: WHITLEY, PAUL E.; LOPEZ, FLAVIO CHAVEZ; IORGA, KAYLA R.
To: PATHEON API SERVICES INC.
Reel/Frame 054138/0223 →